Home > Financial Ratios > BETA DRUGS

BETA DRUGS
Sales/Fixed Asset

    Back to All Ratios
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 2.832.832.502.571.94

What is the latest Sales/Fixed Asset ratio of BETA DRUGS ?

The latest Sales/Fixed Asset ratio of BETA DRUGS is 2.83 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20252.83
Mar20242.83
Mar20232.50
Mar20222.57
Mar20211.94

How is Sales/Fixed Asset of BETA DRUGS Trending?

Years Sales/Fixed Asset % Change
Mar2025 2.83
0.00
Mar2024 2.83
13.20
Mar2023 2.5
-2.72
Mar2022 2.57
32.47
Mar2021 1.94 -

Other Financial Ratios of BETA DRUGS


Compare Sales/Fixed Asset ratio of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹1,979.1 Cr -3.3% -13.7% 1.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


BETA DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-3.3%

-13.7%

1.1%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses